Skip to content

Clinical trials

Prostatic Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Country / region: Brazil Clear all

119 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20073
20084
20092
20102
20115
20124
20136
20148
20156
20164
201710
20183
20197
20209
20215
20228
20234
20243
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Active, not recruiting24
Recruiting16
Unknown status12
Terminated6
No longer available2
Not yet recruiting2
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca12
Sanofi9
Janssen Research & Development, LLC8
Instituto do Cancer do Estado de São Paulo7
Pfizer6
Bristol-Myers Squibb5
Merck Sharp & Dohme LLC5
Aragon Pharmaceuticals, Inc.4
Bayer4
Latin American Cooperative Oncology Group4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms119
Neoplasms7
Breast Neoplasms6
Neoplasm Metastasis5
Erectile Dysfunction3
Esophageal Neoplasms3
Stomach Neoplasms3
Colorectal Neoplasms2
Disease2
Head and Neck Neoplasms2

Trials

Showing 51 to 75 of 119. Each trial links to its page on Pharma Observatory.

19 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.